IDEAYA Biosciences (IDYA) Other Non Operating Income (2018 - 2019)
IDEAYA Biosciences (IDYA) posted Other Non Operating Income of $2000.0 for Q4 2019, down 66.67% sequentially from $6000.0 in Q2 2019.
Powered by 
Analysis
IDEAYA Biosciences (IDYA) Other Non Operating Income (2018 - 2019) Analysis & Trends
IDEAYA Biosciences has reported Other Non Operating Income for 2 years, with the latest figure at $2000.0 in Q4 2019.
- Quarterly Other Non Operating Income changed N/A year-over-year to $2000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $8000.0 (changed N/A YoY) and the FY2019 annual result came in at $8000.0, down 89.61% from the prior year.
- Other Non Operating Income fell to $2000.0 in Q4 2019 per IDYA's latest filing, from $6000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $8000.0 in Q2 2018 and troughed at $1000.0 in Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | IDEAYA Biosciences | 3.65 Bn | 2.82 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 2,000.00 |
| Jun 30, 2019 | 6,000.00 |
| Sep 30, 2018 | 1,000.00 |
| Jun 30, 2018 | 8,000.00 |